A recent outbreak of HIV in Indiana has shed light on the changing risks associated with illicit use of prescription drugs. Since late-2014, there have been 27 confirmed and 10 suspected cases of HIV infection attributed to injection of Opana, an opioid pain reliever marketed by Endo Pharmaceuticals. So how does this latest outbreak relate to the 2012 change of Opana’s formulation? Read our very own Nab Dasgupta’s comments on the case from a harm reduction perspective, along with words from other experts working in the field: Prescription Drug Abuse Linked To Indiana HIV Outbreak

You can explore local and regional data on the street prices of prescription drugs at StreetRx.com.